High flow nasal oxygen in patients with COVID-19 associated acute respiratory failure release_5dmh4hc6wjfvhnze7fx3uwgoae

by Ricard Mellado Artigas, Bruno L. Ferreyro, Federico Angriman, María Hernández-Sanz, Egoitz Arruti, Antoni Torres, Jesús Villar, Laurent Brochard, Carlos Ferrando

Released as a post by Research Square.

2021  

Abstract

<jats:title>Abstract</jats:title> <jats:bold>Purpose</jats:bold>: Whether the use of high-flow nasal oxygen in adult patients with COVID-19 associated acute respiratory failure improves clinically relevant outcomes remains unclear. We thus sought to assess the effect of high-flow nasal oxygen on ventilator-free days, compared to early initiation of invasive mechanical ventilation, on adult patients with COVID-19.<jats:bold>Methods:</jats:bold> We conducted a multicentre cohort study using a prospectively collected database of patients with COVID-19 associated acute respiratory failure admitted to 36 Spanish and Andorran intensive care units (ICUs). Main exposure was the use of high-flow nasal oxygen (conservative group), while early invasive mechanical ventilation (within the first day of ICU admission; early intubation group) served as the comparator. The primary outcome was ventilator-free days at 28 days. ICU length of stay and all-cause in-hospital mortality served as secondary outcomes. We used propensity score matching to adjust for measured confounding.<jats:bold>Results:</jats:bold> Out of 468 eligible patients, a total of 122 matched patients were included in the present analysis (61 for each group). When compared to early intubation, the use of high-flow nasal oxygen was associated with an increase in ventilator-free days (mean difference: 8.0 days; 95% confidence interval (CI): 4.4 to 11.7 days), and a reduction in ICU length of stay (mean difference: -8.2 days; 95% CI -12.7 to -3.6 days). No difference was observed in all-cause in-hospital mortality between groups (odds ratio: 0.64; 95% CI: 0.25 to 1.64).<jats:bold>Conclusions</jats:bold>: The use of high-flow nasal oxygen upon ICU admission in adult patients with COVID-19 related acute hypoxemic respiratory failure may lead to an increase in ventilator-free days and a reduction in ICU length of stay, when compared to early initiation of invasive mechanical ventilation. Future studies should confirm our findings.
In application/xml+jats format

Archived Files and Locations

application/pdf  661.3 kB
file_fvow3ru4krdb7proqxnhyntk3u
assets.researchsquare.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  post
Stage   unknown
Date   2021-01-26
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 78f2c68c-d586-424a-b8d1-7096f2016c1e
API URL: JSON